These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15478573)

  • 1. New advances in chemotherapeutic and supportive care agents for the management of breast cancer patients.
    ONS News; 2004; 19(9 Suppl):23-6. PubMed ID: 15478573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case studies in breast and colorectal cancer for the oncology nurse.
    ONS News; 2004; 19(9 Suppl):47-8. PubMed ID: 15478584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events in bevacizumab and chemotherapy: patient management.
    Blowers E; Hall K
    Br J Nurs; 2009 Apr 9-22; 18(7):424-8. PubMed ID: 19373187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for success: optimizing oral therapies in breast and colorectal cancer.
    Davies MJ
    ONS News; 2006; 21(8 Suppl):7-8. PubMed ID: 16925129
    [No Abstract]   [Full Text] [Related]  

  • 5. Unlocking the clinical mysteries of supportive care: a focus on chemotherapy-induced neutropenia, anemia, and mucositis.
    ONS News; 2004; 19(9 Suppl):27-8. PubMed ID: 15478574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving ahead: challenges with combination therapies for colorectal cancer.
    ONS News; 2004; 19(9 Suppl):13-4. PubMed ID: 15478568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on extended adjuvant therapy options in breast cancer.
    ONS News; 2004; 19(9 Suppl):51-2. PubMed ID: 15478586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current topics in breast cancer for oncology nurses.
    ONS News; 2004; 19(9 Suppl):37-8. PubMed ID: 15478579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-based discussion for the management of metastatic colorectal cancer.
    Biedrzycki BA
    ONS News; 2006; 21(8 Suppl):31-2. PubMed ID: 16925141
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy-induced nausea and vomiting (CINV): prevention, detection, and treatment--how are we doing?
    ONS News; 2004; 19(9 Suppl):61-2. PubMed ID: 15478591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons from the neoadjuvant setting on how best to choose adjuvant therapies.
    von Minckwitz G; Loibl S; Maisch A; Untch M
    Breast; 2011 Oct; 20 Suppl 3():S142-5. PubMed ID: 22015282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. nab-Paclitaxel in combination with biologically targeted agents for early and metastatic breast cancer.
    Megerdichian C; Olimpiadi Y; Hurvitz SA
    Cancer Treat Rev; 2014 Jun; 40(5):614-25. PubMed ID: 24560997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary systemic therapy for operable breast cancer patients: the need for the new generation of trial design.
    Alvarez RH; Hortobagyi GN
    Breast Cancer Res Treat; 2010 Dec; 124(3):701-5. PubMed ID: 20953832
    [No Abstract]   [Full Text] [Related]  

  • 14. Endocrine therapy in breast cancer: the neoadjuvant, adjuvant, and metastatic approach.
    Reinbolt RE; Mangini N; Hill JL; Levine LB; Dempsey JL; Singaravelu J; Koehler KA; Talley A; Lustberg MB
    Semin Oncol Nurs; 2015 May; 31(2):146-55. PubMed ID: 25951743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-related cognitive dysfunction in breast cancer.
    O'Shaughnessy J
    Semin Oncol Nurs; 2003 Nov; 19(4 Suppl 2):17-24. PubMed ID: 14702917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study.
    Semiglazov V; Eiermann W; Zambetti M; Manikhas A; Bozhok A; Lluch A; Tjulandin S; Sabadell MD; Caballero A; Valagussa P; Baselga J; Gianni L
    Eur J Surg Oncol; 2011 Oct; 37(10):856-63. PubMed ID: 21843921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy in stage III breast cancer.
    Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
    Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant systemic treatment for individual patients with triple negative breast cancer.
    Oakman C; Moretti E; Galardi F; Biagioni C; Santarpia L; Biganzoli L; Di Leo A
    Breast; 2011 Oct; 20 Suppl 3():S135-41. PubMed ID: 22015281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of neo-adjuvant sequential dose-dense chemotherapy doublets combined with trastuzumab in patients with HER-2-positive early stage breast cancer.
    Sánchez-Muñoz A; García-Tapiador AM; Dueñas-García R; Jaén-Morago A; Ortega-Granados AL; Martínez-Ortega E; Fernández Morales M; Fernández-Navarro M; de la Torre Cabrera C; Dueñas B; Ureña C; Martínez J; Morales F; Ramírez-Tortosa C; Sánchez-Rovira P
    Breast J; 2008; 14(5):506-7. PubMed ID: 18705667
    [No Abstract]   [Full Text] [Related]  

  • 20. Is drug-induced toxicity a good predictor of response to neo-adjuvant chemotherapy in patients with breast cancer?--a prospective clinical study.
    Chintamani ; Singhal V; Singh JP; Lyall A; Saxena S; Bansal A
    BMC Cancer; 2004 Aug; 4():48. PubMed ID: 15310398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.